ASAP announces new teams joining the Collaborative Research Network! Learn More
Aligning Science Across Parkinson's Logo Text

Chemogenetic modulation of catecholaminergic neurons

Output Details

This protocol outlines a method for modulating noradrenergic and dopaminergic neuronal activity in the LC and SNc-VTA, respectively, using Cre-dependent hM3D and hM4D expression. It details stereotactic injection techniques for these chemogenetic tools and the preparation of the J60 agonist for intraperitoneal delivery. Developed for longitudinal studies spanning up to four weeks, the protocol aims to assess neuromelanin's activity-dependent accumulation through daily agonist administration.
Tags
  • Animal

Meet the Authors

  • User avatar fallback logo

    Cristian Gonzalez-Cabrera

    External Collaborator

  • User avatar fallback logo

    Csilla Novák

    External Collaborator

  • User avatar fallback logo

    Maria Paz Contreras Santander

    External Collaborator

  • User avatar fallback logo

    Ernesto Durán

    External Collaborator

  • Matthias Prigge, PhD

    Co-PI (Core Leadership): Team Vila

    Leibniz Institute for Neurobiolog

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.